Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.46

Lifecome Biochemistry Co.,Ltd. Revenue Per Share is USD 0.46 for the year ending December 31, 2023, a 48.78% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Lifecome Biochemistry Co.,Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.31, a -16.42% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.37, a 21.14% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.31, a 10.06% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.28, a -12.86% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years